본문 바로가기
KERD
논문KCI 등재

Comparison of an Endoscopic Scoring System and the Simplified Magnetic Resonance Index of Activity in Patients with Small Bowel Crohn’s Disease

김영호|홍성노|Kim Ji Eun|장동경|송경두|Kim Eun Ran|Na Ji Eun|Kim Honsoul
거트앤리버 소화기연관학회협의회|2024.01|Gut and Liver|제18권 제1호|pp. 97-105|DOI 10.5009/gnl220422

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

Crohn diseaseSimplified MARIAIleal SES-CDa/SES-CD

초록

Background/Aims: The newly derived simplified magnetic resonance index of activity (MARIAs) has not been verified in comparison to balloon-assisted enteroscopy (BAE) for patients with small bowel Crohn’s disease (CD). We studied the correlation of MARIAs with simple endoscopic scores for CD (SES-CD) of the ileum based on magnetic resonance enterography (MRE) and BAE in patients with small bowel CD. Methods: Fifty patients with small bowel CD who underwent BAE and MRE concurrently within 3 months from September 2020 to June 2021 were enrolled in the study. The primary outcome was the correlation between the active score of ileal SES-CD (ileal SES-CDa)/ileal SES-CD and MARIAs based on BAE and MRE. The cutoff value for MARIAs identifying endoscopically active/severe disease, defined as ileal SES-CDa/ileal SES-CD of 5/7 or more, was analyzed. Results: Ileal SES-CDa/ileal SES-CD and MARIAs showed strong associations (R=0.76, p<0.001; R=0.78, p<0.001). The area under the receiver operating characteristic curve of MARIAs for ileal SES-CDa ≥5 and ileal SES-CD ≥7 was 0.92 (95% confidence interval, 0.88 to 0.97) and 0.92 (95% confidence interval, 0.87 to 0.97). The cutoff value of MARIAs for detecting active/severe disease was 3. A MARIAs index value of ≥3 identified ileal SES-CDa ≥5 with a sensitivity of 85% and specificity of 87% and detected ileal SES-CD ≥7 with a sensitivity of 87% and specificity of 86%. Conclusions: This study validated the applicability of MARIAs compared to BAE-based ileal SES-CDa/SES-CD.

Abstract

Background/Aims: The newly derived simplified magnetic resonance index of activity (MARIAs) has not been verified in comparison to balloon-assisted enteroscopy (BAE) for patients with small bowel Crohn’s disease (CD). We studied the correlation of MARIAs with simple endoscopic scores for CD (SES-CD) of the ileum based on magnetic resonance enterography (MRE) and BAE in patients with small bowel CD. Methods: Fifty patients with small bowel CD who underwent BAE and MRE concurrently within 3 months from September 2020 to June 2021 were enrolled in the study. The primary outcome was the correlation between the active score of ileal SES-CD (ileal SES-CDa)/ileal SES-CD and MARIAs based on BAE and MRE. The cutoff value for MARIAs identifying endoscopically active/severe disease, defined as ileal SES-CDa/ileal SES-CD of 5/7 or more, was analyzed. Results: Ileal SES-CDa/ileal SES-CD and MARIAs showed strong associations (R=0.76, p<0.001; R=0.78, p<0.001). The area under the receiver operating characteristic curve of MARIAs for ileal SES-CDa ≥5 and ileal SES-CD ≥7 was 0.92 (95% confidence interval, 0.88 to 0.97) and 0.92 (95% confidence interval, 0.87 to 0.97). The cutoff value of MARIAs for detecting active/severe disease was 3. A MARIAs index value of ≥3 identified ileal SES-CDa ≥5 with a sensitivity of 85% and specificity of 87% and detected ileal SES-CD ≥7 with a sensitivity of 87% and specificity of 86%. Conclusions: This study validated the applicability of MARIAs compared to BAE-based ileal SES-CDa/SES-CD.

참고문헌 (41)

  1. Peyrin-Biroulet L, "Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE) : determining therapeutic goals for treat-to-target", Am J Gastroenterol, 110, pp.1324~1338 (2015)
  2. Turner D, "STRIDE-II : an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE)initiative of the International Organization for the Study of IBD(IOIBD) : determining therapeutic goals for treat-to-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
  3. Cicero G, "Crohn’s disease at radiological imaging : focus on techniques and intestinal tract", Intest Res, 19, pp.365~378 (2021)
  4. Cho CW, "Long-term disease course of Crohn’s disease : changes in disease location, phenotype, activities, and predictive factors", Gut Liver, 16, pp.157~170 (2022)
  5. Castiglione F, "One-year clinical outcomes with biologics in Crohn’s disease : transmural healing compared with mucosal or no healing", Aliment Pharmacol Ther, 49, pp.1026~1039 (2019)
  6. Paredes JM, "Clinical impact of sonographic transmural healing after anti-TNF antibody treatment in patients with Crohn’s disease", Dig Dis Sci, 64, pp.2600~2606 (2019)
  7. Orlando S, "Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn’s disease treated with anti-tumour necrosis factor antibodies", J Crohns Colitis, 12, pp.63~70 (2018)
  8. Sauer CG, "Magnetic resonance enterography healing and magnetic resonance enterography remission predicts improved outcome in pediatric Crohn disease", J Pediatr Gastroenterol Nutr, 62, pp.378~383 (2016)
  9. Fernandes SR, "Transmural healing is associated with improved long-term outcomes of patients with Crohn’s disease", Inflamm Bowel Dis, 23, pp.1403~1409 (2017)
  10. Deepak P, "Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn’s disease", Am J Gastroenterol, 111, pp.997~1006 (2016)
  11. Hallé E, "Radiological response is associated with better outcomes and should be considered a therapeutic target in Crohn’s disease", Dig Dis Sci, 65, pp.2664~2674 (2020)
  12. Buisson A, "Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn’s disease", J Gastroenterol, 54, pp.312~320 (2019)
  13. Lafeuille P, "Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease", Aliment Pharmacol Ther, 53, pp.577~586 (2021)
  14. Ripollés T, "Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease : a multicenter study", Inflamm Bowel Dis, 22, pp.2465~2473 (2016)
  15. Castiglione F, "Transmural healing evaluated by bowel sonography in patients with Crohn’s disease on maintenance treatment with biologics", Inflamm Bowel Dis, 19, pp.1928~1934 (2013)
  16. Noh SM, "Association of faecal calprotectin level and combined endoscopic and radiological healing in patients with Crohn’s disease receiving anti-tumour necrosis factor therapy", J Crohns Colitis, 14, pp.1231~1240 (2020)
  17. Civitelli F, "Looking beyond mucosal healing : effect of biologic therapy on transmural healing in pediatric Crohn’s disease", Inflamm Bowel Dis, 22, pp.2418~2424 (2016)
  18. Laterza L, "Multiparametric evaluation predicts different mid-term outcomes in Crohn’s disease", Dig Dis, 36, pp.184~193 (2018)
  19. Nehra AK, "Imaging findings of ileal inflammation at computed tomography and magnetic resonance enterography : what do they mean when ileoscopy and biopsy are negative?", J Crohns Colitis, 14, pp.455~464 (2020)
  20. Jeon SR, "Enteroscopy in Crohn’s disease:are there any changes in role or outcomes over time? A KASID multicenter study", Gut Liver, 15, pp.375~382 (2021)
  21. Ordás I, "Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease", Gastroenterology, 146, pp.374~382 (2014)
  22. Takenaka K, "Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn’s disease", Am J Gastroenterol, 113, pp.283~294 (2018)
  23. Takenaka K, "Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn’s disease", Inflamm Bowel Dis, 21, pp.1832~1838 (2015)
  24. Rimola J, "Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease", Gut, 58, pp.1113~1120 (2009)
  25. Takenaka K, "Objective evaluation for treat to target in Crohn’s disease", J Gastroenterol, 55, pp.579~587 (2020)
  26. Rozendorn N, "A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation", Therap Adv Gastroenterol, 11, pp.1756284818765956~ (2018)
  27. Rimola J, "Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease", J Gastroenterol, 52, pp.585~593 (2017)
  28. Ordás I, "Development and validation of a simplified magnetic resonance index of activity for Crohn’s disease", Gastroenterology, 157, pp.432~439 (2019)
  29. Tao Y, "Can the simplified magnetic resonance index of activity be used to evaluate the degree of activity in Crohn’s disease?", BMC Gastroenterol, 21, pp.409~ (2021)
  30. Roseira J, "The new simplified MARIA score applies beyond clinical trials : a suitable clinical practice tool for Crohn’s disease that parallels a simple endoscopic index and fecal calprotectin", United European Gastroenterol J, 8, pp.1208~1216 (2020)
  31. without gadolinium-enhanced sequences for Crohn’s disease, "J Crohns Colitis", 2020, 1074~1081
  32. Bruining DH, "Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease", Radiology, 286, pp.776~799 (2018)
  33. Guglielmo FF, "Small bowel Crohn disease at CT and MR enterography : imaging atlas and glossary of terms", Radiographics, 40, pp.354~375 (2020)
  34. Takenaka K, "Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn’s disease", Gastroenterology, 147, pp.334~342 (2014)
  35. Kopylov U, "Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease", Therap Adv Gastroenterol, 9, pp.655~663 (2016)
  36. Castiglione F, "Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with anti-TNF alpha agents", Dig Liver Dis, 49, pp.484~489 (2017)
  37. Weinstein-Nakar I, "Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn’s disease", Clin Gastroenterol Hepatol, 16, pp.1089~1097 (2018)
  38. Samuel S, "Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy", Clin Gastroenterol Hepatol, 10, pp.1253~1259 (2012)
  39. Watanabe K, "Clinical management for small bowel of Crohn’s disease in the treat-to-target era : now is the time to optimize treatment based on the dominant lesion", Intest Res, 18, pp.347~354 (2020)
  40. Takenaka K, "Small bowel healing detected by endoscopy in patients with Crohn’s disease after treatment with antibodies against tumor necrosis factor", Clin Gastroenterol Hepatol, 18, pp.1545~1552 (2020)
  41. Hong SW, "Clinical features and longterm prognosis of Crohn’s disease in Korea : results from the prospective CONNECT study", Gut Liver, 16, pp.907~920 (2022)

관련 논문AI추천

Comprehensive Review of Magnetic Resonance Enterography-Based Activity Scoring Systems for Crohn’s Disease서니은대한자기공명의과학회 · Investigative Magnetic Resonance Imaging2025 · 제29권 제1호Endoscopic activity in inflammatory bowel disease: clinical significance and application in practiceKyeong Ok Kim대한소화기내시경학회 · Clinical Endoscopy2022 · 제55권 제4호Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn’s Disease: A Propensity Score-Matched StudyHaruhiko Ogata, Kaoru Takabayashi, Kayoko Fukuhara, Kosaku Nanki, Makoto Mutaguchi, Makoto Naganuma, Motohiko Kato, Naohisa Yahagi, Naoki Hosoe, Ryoichi Miyanaga, Shinta Mizuno, Takanori Kanai, Tomohisa Sujino, Yohei Mikami, Yukie Hayashi거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호Enteroscopy in Crohn’s Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study박수정, Byeon Jeong-Sik, Chang Dong Kyung, Eun Chang Soo, Goong Hyeon Jeong, Hong Sung Noh, Im Jong Pil, Jang Hyun Joo, Jeon Seong Ran, Kim Eun Ran, Kim Jin-Oh, Kim Seong-Eun, Ko Bong Min, Koo Ja Seol, Small Intestine Research Group of the Korean Association for the Study of Intestinal Diseases, Yang Dong-Hoon거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제3호Chronological Review of Endoscopic Indices in Inflammatory Bowel Disease김은수, Joon Seop Lee, Won Moon대한소화기내시경학회 · Clinical Endoscopy2019 · 제52권 제2호Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement김원호, 김태일, 박수정, 박재준, 박지혜, 천재희, Eun Ae Kang, Hye Kyung Hyun, Jongwook Yu대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제3호

이 간행물의 다른 논문 (22건)

Delayed Perforation after Gastric Endoscopic Submucosal Dissection: Proceed to Prompt Intervention If AcceptableAbe Seiichiropp. 1-2The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular CarcinomaKim Beom Kyungpp. 3-4Investigating Alternative Treatment Options Unfeasible for Local Ablation Therapy in Patients with Small Solitary Hepatocellular Carcinomas김인희, 이창훈pp. 5-6Non-Contrast Abbreviated Magnetic Resonance Imaging: A Cost-Effective Rookie in Hepatocellular Carcinoma Surveillance for Cirrhotic PatientsHeo Subin, Choi Won-Mookpp. 7-9Clinical Practice Guideline for Percutaneous Endoscopic GastrostomyGong Eun Jeong, Park Chan Hyuk, Lee Moon Sung, 임철현, 김상훈, 이주엽, Choi Miyoung, 심기남, Byeon Jeong-Sik, 송근암, Shin Cheol Min, Lim Hyun, Joo Moon Kyung, Choi Hyuk Soon, Lee Oh Young, Park Jong-Jae, 태정현pp. 10-26
원문 보기